Hormones and breast cancer

This publication has 23 references indexed in Scilit:

• Adjuvant systemic therapy: State of the art, 1989
  Breast Cancer Research and Treatment, 1989
• Effects of Tamoxifen, Tamoxifen Metabolites, and Nafoxidine on Adenosine 3′,5′-Monophosphate Phosphodiesterase: Correlations with Growth Inhibitory Activities but not Estrogen Receptor Affinities^*
  Endocrinology, 1989
• Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow Cytometry
  New England Journal of Medicine, 1989
• A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors
  New England Journal of Medicine, 1989
• Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer
  New England Journal of Medicine, 1988
• Expression of Transforming Growth Factor α and its Messenger Ribonucleic Acid in Human Breast Cancer: Its Regulation by Estrogen and its Possible Functional Significance
  Molecular Endocrinology, 1988
• DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens
  Cancer, 1988
• Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.
  Journal of Clinical Oncology, 1987
• Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.
  Journal of Clinical Oncology, 1984
• Progesterone Receptors as a Prognostic Factor in Stage II Breast Cancer
  New England Journal of Medicine, 1983